GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Policy Acquisition Expense

InNexus Biotechnology (InNexus Biotechnology) Policy Acquisition Expense


View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


InNexus Biotechnology (InNexus Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.